Originally developed for the treatment of type 2 diabetes, these peptide-based drugs are now at the forefront of both metabolic disease management and obesity treatment, driving unprecedented market growth and industry attention
AOD9604 vs Intact hGH in Obesity Models A direct head-to-head comparison of AOD9604 and intact hGH in obese and lean mice confirmed that both compounds significantly reduced body weight gain in obese animals through increased fat oxidation and lipolysis stimulation but that AOD9604 achieved this without the hGH receptor binding, IGF-1 stimulation, hyperglycaemia, or reduced insulin secretion associated with full-length hGH treatment
These were the first brands we worked with and we continue to identify with their ethosfor us, theres nothing better than gentle skincare products that focus on resolving skin concerns without disrupting the skin barrier
Novo Nordisk, which owns the patent for Ozempic, now has a market cap bigger than its home country Denmarks gross domestic product
Dao, K., et al
Recent studies have begun to investigate its potential to support brain health and alleviate symptoms of anxiety and depression